Newborn size may predict paternal diabetes risk

The parents of newborn babies who are small are at increased risk for developing diabetes later in life, suggest findings from a study of an Indian population.

"This suggests a genetic or epigenetic link between diabetes risk in either parent and reduced fetal growth in their children," say Sargoor Veena (Holdsworth Memorial Hospital, Mysore, Karanataka, India) and colleagues.

Several studies have reported that low offspring birth size is linked to an elevated risk for diabetes, but such studies have been mainly limited to birth weight, which reflects a crude composite of bone, fat, muscle, and visceral mass, remark Veena and team.

"These components may have different relationships with long-term health outcomes in the parents," they say.

In the current study, the researchers analyzed data from The Mysore Parthenon Study, including detailed neonatal anthropometric data as well as 9.5 year follow-up data on parents' glycemic parameters.

As reported in Diabetes Care, 62 (15.6%) of 398 fathers and 22 (4.7%) of 469 mothers who were not diabetic at the time of pregnancy, developed diabetes.

There was a significant inverse relationship between measurements of neonatal size and incidence of diabetes among parents.

Parents of babies in the highest versus lowest quintile for birth weight, mid-upper arm circumference (MUAC), arm muscle area, and tricep and subscapular skinfold thickness were at a significantly decreased risk for incident diabetes, at odds ratios 0.3, 0.6, 0.7, and 0.7, respectively.

"This is consistent with the fetal insulin hypothesis…common genetic factors that either increase insulin resistance or reduce insulin secretion, leading to both low birth weight and disease in later life," write Veena and team.

In addition, birth weight, MUAC, abdominal circumference, and skinfold thickness showed clear U-shaped associations with diabetes prevalence among mothers.

"This suggests either that predictable changes in the mother during pregnancy (other than her glucose concentrations) increase fetal adiposity or that fetal adiposity induces maternal diabetes," say the researchers.

The team says the study "adds to very few other studies that have shown these two effects so clearly."

Licensed from medwireNews with permission from Springer Healthcare Ltd. ©Springer Healthcare Ltd. All rights reserved. Neither of these parties endorse or recommend any commercial products, services, or equipment.

Sally Robertson

Written by

Sally Robertson

Sally first developed an interest in medical communications when she took on the role of Journal Development Editor for BioMed Central (BMC), after having graduated with a degree in biomedical science from Greenwich University.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Robertson, Sally. (2018, August 23). Newborn size may predict paternal diabetes risk. News-Medical. Retrieved on November 16, 2024 from https://www.news-medical.net/news/20120710/Newborn-size-may-predict-paternal-diabetes-risk.aspx.

  • MLA

    Robertson, Sally. "Newborn size may predict paternal diabetes risk". News-Medical. 16 November 2024. <https://www.news-medical.net/news/20120710/Newborn-size-may-predict-paternal-diabetes-risk.aspx>.

  • Chicago

    Robertson, Sally. "Newborn size may predict paternal diabetes risk". News-Medical. https://www.news-medical.net/news/20120710/Newborn-size-may-predict-paternal-diabetes-risk.aspx. (accessed November 16, 2024).

  • Harvard

    Robertson, Sally. 2018. Newborn size may predict paternal diabetes risk. News-Medical, viewed 16 November 2024, https://www.news-medical.net/news/20120710/Newborn-size-may-predict-paternal-diabetes-risk.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Digital health technologies play a transformative role in diabetes management and prevention